Stay updated on ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer
Sign up to get notified when there's something new on the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page.
Latest updates to the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.0%
- Check23 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the 'Contacts and Locations' section in the study record.SummaryDifference1%
- Check38 days agoChange DetectedSeveral key resources related to ovarian cancer, including links to MedlinePlus and NIH, have been removed, which may impact access to important genetic and treatment information.SummaryDifference3%
- Check45 days agoChange DetectedThe website has been updated to version 2.12.2, with new additions including links to resources on ovarian cancer and related treatments, as well as options for downloading study data in various formats.SummaryDifference3%
- Check59 days agoChange DetectedThe website has been updated from version v2.11.2 to v2.12.1, indicating a new release with potential improvements or features.SummaryDifference0.1%
- Check92 days agoChange DetectedThe website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.SummaryDifference0.0%
Stay in the know with updates to ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer
Enter your email address, and we'll notify you when there's something new on the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page.